nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—PTGS1—esophageal cancer	0.756	1	CbGaD
Ketobemidone—CYP2C9—Capecitabine—esophageal cancer	0.0358	0.407	CbGbCtD
Ketobemidone—CYP2B6—Cisplatin—esophageal cancer	0.0342	0.388	CbGbCtD
Ketobemidone—CYP2C9—Cisplatin—esophageal cancer	0.018	0.205	CbGbCtD
Ketobemidone—CYP2B6—Metabolism—ALOX15—esophageal cancer	3.9e-05	0.00025	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	3.85e-05	0.000246	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GSTT1—esophageal cancer	3.78e-05	0.000242	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	3.77e-05	0.000241	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	3.75e-05	0.00024	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.74e-05	0.000239	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP2A6—esophageal cancer	3.74e-05	0.000239	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.72e-05	0.000238	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTO1—esophageal cancer	3.72e-05	0.000238	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TPI1—esophageal cancer	3.72e-05	0.000238	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ADH7—esophageal cancer	3.71e-05	0.000238	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PLCE1—esophageal cancer	3.71e-05	0.000238	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP1B1—esophageal cancer	3.7e-05	0.000237	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.67e-05	0.000235	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ADH1B—esophageal cancer	3.65e-05	0.000233	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CA2—esophageal cancer	3.64e-05	0.000233	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALDOB—esophageal cancer	3.57e-05	0.000228	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.56e-05	0.000228	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	3.55e-05	0.000227	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ENO1—esophageal cancer	3.54e-05	0.000227	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	3.51e-05	0.000224	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PSME2—esophageal cancer	3.5e-05	0.000224	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PSME1—esophageal cancer	3.5e-05	0.000224	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PSME2—esophageal cancer	3.49e-05	0.000224	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PSME1—esophageal cancer	3.49e-05	0.000224	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	3.49e-05	0.000223	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TYMP—esophageal cancer	3.48e-05	0.000223	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CYP19A1—esophageal cancer	3.48e-05	0.000222	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GAPDH—esophageal cancer	3.44e-05	0.00022	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CRABP1—esophageal cancer	3.4e-05	0.000218	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SST—esophageal cancer	3.39e-05	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	3.39e-05	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.38e-05	0.000217	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ADH7—esophageal cancer	3.38e-05	0.000217	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	3.36e-05	0.000215	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.35e-05	0.000214	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	3.31e-05	0.000212	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—GHRL—esophageal cancer	3.31e-05	0.000212	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALOX15—esophageal cancer	3.3e-05	0.000211	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ADH1B—esophageal cancer	3.25e-05	0.000208	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	3.25e-05	0.000208	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GNG7—esophageal cancer	3.24e-05	0.000207	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—HMOX1—esophageal cancer	3.17e-05	0.000203	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTO1—esophageal cancer	3.15e-05	0.000202	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TPI1—esophageal cancer	3.15e-05	0.000202	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.11e-05	0.000199	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	3.11e-05	0.000199	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TYMP—esophageal cancer	3.11e-05	0.000199	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.09e-05	0.000198	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.09e-05	0.000198	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.05e-05	0.000195	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ABCB1—esophageal cancer	3.04e-05	0.000195	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALDH2—esophageal cancer	3.03e-05	0.000194	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP26A1—esophageal cancer	3.03e-05	0.000194	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALDOB—esophageal cancer	3.02e-05	0.000193	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP1B1—esophageal cancer	3.01e-05	0.000193	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.97e-05	0.00019	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	2.96e-05	0.00019	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.95e-05	0.000189	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	2.95e-05	0.000189	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.91e-05	0.000186	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.89e-05	0.000185	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.88e-05	0.000184	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2.85e-05	0.000183	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TYMP—esophageal cancer	2.84e-05	0.000181	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.83e-05	0.000181	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.81e-05	0.00018	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TPI1—esophageal cancer	2.81e-05	0.00018	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.76e-05	0.000177	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	2.75e-05	0.000176	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GNG7—esophageal cancer	2.74e-05	0.000175	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS1—esophageal cancer	2.7e-05	0.000173	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ENO1—esophageal cancer	2.7e-05	0.000173	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.7e-05	0.000173	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.69e-05	0.000172	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PSME2—esophageal cancer	2.67e-05	0.000171	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PSME1—esophageal cancer	2.67e-05	0.000171	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	2.63e-05	0.000168	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—KDR—esophageal cancer	2.63e-05	0.000168	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.62e-05	0.000168	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CA1—esophageal cancer	2.62e-05	0.000168	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.6e-05	0.000166	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—HMOX1—esophageal cancer	2.59e-05	0.000165	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.57e-05	0.000165	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.57e-05	0.000164	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.56e-05	0.000164	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TPI1—esophageal cancer	2.56e-05	0.000164	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.54e-05	0.000162	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	2.49e-05	0.000159	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ABCB1—esophageal cancer	2.48e-05	0.000159	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	2.48e-05	0.000158	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.46e-05	0.000157	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GNG7—esophageal cancer	2.45e-05	0.000157	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.44e-05	0.000156	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.42e-05	0.000155	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	2.41e-05	0.000154	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.41e-05	0.000154	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CA2—esophageal cancer	2.4e-05	0.000154	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.37e-05	0.000151	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.35e-05	0.00015	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—KDR—esophageal cancer	2.31e-05	0.000148	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.3e-05	0.000147	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP1B1—esophageal cancer	2.3e-05	0.000147	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALDH2—esophageal cancer	2.29e-05	0.000147	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.29e-05	0.000147	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ENO1—esophageal cancer	2.29e-05	0.000147	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PSME1—esophageal cancer	2.26e-05	0.000144	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PSME2—esophageal cancer	2.26e-05	0.000144	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	2.25e-05	0.000144	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADH7—esophageal cancer	2.23e-05	0.000143	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.23e-05	0.000143	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GNG7—esophageal cancer	2.23e-05	0.000143	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	2.21e-05	0.000141	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTT1—esophageal cancer	2.18e-05	0.00014	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	2.17e-05	0.000139	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CYP19A1—esophageal cancer	2.16e-05	0.000138	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP2A6—esophageal cancer	2.16e-05	0.000138	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.15e-05	0.000137	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.11e-05	0.000135	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.09e-05	0.000134	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ENO1—esophageal cancer	2.04e-05	0.000131	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS1—esophageal cancer	2.04e-05	0.000131	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	2.04e-05	0.00013	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CREBBP—esophageal cancer	2.03e-05	0.00013	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PSME2—esophageal cancer	2.01e-05	0.000129	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PSME1—esophageal cancer	2.01e-05	0.000129	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NOS3—esophageal cancer	2.01e-05	0.000129	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.99e-05	0.000127	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.97e-05	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.97e-05	0.000126	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	1.97e-05	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.97e-05	0.000126	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.96e-05	0.000125	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.96e-05	0.000125	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—KDR—esophageal cancer	1.95e-05	0.000125	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.95e-05	0.000125	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	1.93e-05	0.000124	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	1.91e-05	0.000123	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.89e-05	0.000121	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	1.88e-05	0.00012	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.88e-05	0.00012	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TYMP—esophageal cancer	1.87e-05	0.00012	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ENO1—esophageal cancer	1.86e-05	0.000119	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.86e-05	0.000119	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.85e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PSME2—esophageal cancer	1.84e-05	0.000118	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PSME1—esophageal cancer	1.84e-05	0.000118	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	1.84e-05	0.000117	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.83e-05	0.000117	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NOS3—esophageal cancer	1.82e-05	0.000117	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.82e-05	0.000116	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.77e-05	0.000113	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOS3—esophageal cancer	1.76e-05	0.000113	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.76e-05	0.000113	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.74e-05	0.000111	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TPI1—esophageal cancer	1.69e-05	0.000108	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.69e-05	0.000108	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	1.68e-05	0.000107	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.67e-05	0.000107	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—esophageal cancer	1.67e-05	0.000107	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	1.66e-05	0.000106	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CCND1—esophageal cancer	1.66e-05	0.000106	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CREBBP—esophageal cancer	1.66e-05	0.000106	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	1.65e-05	0.000106	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.64e-05	0.000105	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	1.64e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.63e-05	0.000105	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.62e-05	0.000104	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	1.61e-05	0.000103	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.6e-05	0.000103	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.6e-05	0.000103	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.58e-05	0.000101	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.56e-05	0.0001	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.56e-05	9.99e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.55e-05	9.9e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EP300—esophageal cancer	1.53e-05	9.79e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.49e-05	9.54e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.49e-05	9.53e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOS3—esophageal cancer	1.49e-05	9.53e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NOS3—esophageal cancer	1.49e-05	9.5e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GNG7—esophageal cancer	1.47e-05	9.42e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.46e-05	9.36e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCND1—esophageal cancer	1.46e-05	9.32e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.43e-05	9.16e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.42e-05	9.08e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	1.41e-05	9.02e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	1.39e-05	8.92e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—EP300—esophageal cancer	1.39e-05	8.87e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.38e-05	8.82e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.36e-05	8.7e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—esophageal cancer	1.36e-05	8.69e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EP300—esophageal cancer	1.34e-05	8.58e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.33e-05	8.53e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MYC—esophageal cancer	1.33e-05	8.53e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.31e-05	8.39e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.3e-05	8.35e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—esophageal cancer	1.3e-05	8.34e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.3e-05	8.3e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CREBBP—esophageal cancer	1.27e-05	8.1e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCND1—esophageal cancer	1.23e-05	7.88e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.23e-05	7.86e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ENO1—esophageal cancer	1.23e-05	7.86e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.21e-05	7.76e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PSME1—esophageal cancer	1.21e-05	7.75e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PSME2—esophageal cancer	1.21e-05	7.75e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	1.19e-05	7.62e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MYC—esophageal cancer	1.17e-05	7.48e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—esophageal cancer	1.14e-05	7.31e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EP300—esophageal cancer	1.13e-05	7.25e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NOS3—esophageal cancer	1.13e-05	7.25e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	1.13e-05	7.24e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—EP300—esophageal cancer	1.13e-05	7.23e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TP53—esophageal cancer	1.09e-05	7e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.08e-05	6.92e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.07e-05	6.86e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.05e-05	6.69e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—esophageal cancer	1.04e-05	6.63e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3CA—esophageal cancer	1.03e-05	6.56e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	9.92e-06	6.35e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MYC—esophageal cancer	9.88e-06	6.32e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.87e-06	6.31e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.83e-06	6.29e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—esophageal cancer	9.66e-06	6.18e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TP53—esophageal cancer	9.6e-06	6.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NOS3—esophageal cancer	9.59e-06	6.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CREBBP—esophageal cancer	9.56e-06	6.12e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.97e-06	5.74e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—esophageal cancer	8.77e-06	5.62e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CREBBP—esophageal cancer	8.72e-06	5.58e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—EP300—esophageal cancer	8.62e-06	5.52e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.61e-06	5.51e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NOS3—esophageal cancer	8.56e-06	5.48e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	8.38e-06	5.36e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3CA—esophageal cancer	8.36e-06	5.35e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TP53—esophageal cancer	8.11e-06	5.19e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—esophageal cancer	7.83e-06	5.01e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NOS3—esophageal cancer	7.81e-06	5e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—EP300—esophageal cancer	7.3e-06	4.67e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—esophageal cancer	7.14e-06	4.57e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—EP300—esophageal cancer	6.51e-06	4.17e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3CA—esophageal cancer	6.38e-06	4.08e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—EP300—esophageal cancer	5.94e-06	3.8e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.75e-06	3.68e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	5.4e-06	3.45e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NOS3—esophageal cancer	5.15e-06	3.3e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3CA—esophageal cancer	4.82e-06	3.08e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.71e-06	3.01e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4.39e-06	2.81e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—EP300—esophageal cancer	3.92e-06	2.51e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.9e-06	1.85e-05	CbGpPWpGaD
